Viewpoints: Age Limits Shouldn’t Block Access To Breakthrough Drugs; Good Riddance To Illegal NIH Funding Cuts
Editorial writers discuss these public health issues.
Archives: Morning Breakouts
221 - 240 of 112,246 Results
-
-
White House To Voters: We’re Fixing Health Care With Doc-Focused Strategy
Heading toward the midterm elections, the Trump administration will argue that its agenda is addressing issues including too few physicians and too much paperwork, The Washington Post reported. But critics have pointed to other administration policies, including the significant reductions to Medicaid funding, as harmful.
By khnlaureno -
Fluoride In Drinking Water Does Not Cause IQ Loss, US Study Shows
The first long-term study in the U.S. shows that drinking fluoridated water has no negative effect on cognition up to the age of 80. The use of fluoridated water has been shown to reduce tooth decay by 25%. Two states have banned the mineral, while several others have similar legislation pending.
By khnlaureno -
Eye Doctor Being Considered To Replace Prasad As Vaccine Regulator
Houman Hemmati, who criticized the government's response to the covid pandemic, is in the running to replace Vinay Prasad as the director of the FDA’s Center for Biologics Evaluation and Research, sources told The Washington Post.
By khnlaureno -
Pill For Metastatic Pancreatic Cancer Helped Patients Live Twice As Long
Stat reported that patients who took the daily pill, called daraxonrasib, lived a median of 13.2 months compared with 6.7 months for patients who received chemotherapy. One of the trial's participants, former U.S. Sen. Ben Sasse of Nebraska, said, "This experience has seemingly extended both quantity and quality of [my] life.”
By khnlaureno -
First Edition: Tuesday, April 14, 2026
Today's early morning highlights from the major news organizations.
By khnlaureno -
Hospitals Look To Chatbots To Serve Current Patients, Attract New Ones
Stat reports that some health systems are trying to find a way to reach the huge proportion of people turning to AI for health care questions. Also: ER workers weigh in on nine things "The Pitt" gets right.
By khnlaureno -
States Adjust To Rising Temperatures That Put Student Athletes At Risk
There are no national standards for schools regarding heat safety. Until there are federal regulations in place, schools will continue to be constrained by their budgets. Also: red light therapy; reversing cellular aging; and more.
By khnlaureno -
Viewpoints: Mass. Health Reform Is A Model For All States; ‘Portable Benefits’ Open Health Care To Freelancers
Opinion writers delve into these public health topics.
By khnelysiag -
CMS Wants To Speed Up Prior Authorization Decisions For Rx Drugs
Health insurance companies and states would also have to publicly disclose their denial rates for meds. Meanwhile, Medicare enrollees will soon have access to a digital health record system, enabling them to share records with providers.
By khnlaureno -
Americans Lean In To Meatier Diet, Despite Health Concerns It Raises
The protein craze promoted by Health Secretary Robert F. Kennedy Jr. has more people adding red meat and poultry to their diets. Health experts say overloading on inflammation-inducing saturated fats and meat-based minerals can cause myriad problems. Plus, the nonbuzz about raw milk.
By khnlaureno -
Covid Might Be Spread By Lung Protein Mechanism, Researchers Find
Lungs have been found to release protein particles that the covid virus needs to enter healthy cells. Those particles move throughout the body, expanding the number of cells the virus can infect and causing immune and blood vessel cells to become vulnerable. This discovery of cell-to-cell communication might lead to better treatment for infections.
By khnlaureno -
With Funds Frozen, Minnesota Sweeps Medicaid Providers For Signs Of Fraud
Inspectors aren't finding evidence of widespread fraud, state Medicaid director John Connolly said, adding the revalidation process of more than 5,000 providers should be completed by the end of May. Plus: Louisiana's anti-abortion effort; punitive damages in an infant formula case; and more.
By khnlaureno -
First Edition: Monday, April 13, 2026
Today's early morning highlights from the major news organizations.
By khnlaureno -
BuzzBallz, Biggies, Boulders: Punchy Trend Stirs Buzz About Teen Drinking
The high-alcohol libations are packaged in pretty colors and concocted with flavors reminiscent of childhood drinks — an appealing mix to underage consumers, a substance abuse expert claims. Plus, a family blames an energy drink for the death of their Texas teen.
By khnlaureno -
Longer Looks: Interesting Reads You Might Have Missed
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on Artemis II, people who are in a persistent vegetative state, the health effects of plastic, and more.
By khnlaureno -
Viewpoints: Two Raw Milk Outbreaks With Two Different Responses; Lessons Public Health Can Learn From MAHA
Opinion writers examine these public health issues.
By khnelysiag -
New ACIP Charter, Published Thursday, Revises Purpose Of Panel, Who’s On It
As The New York Times reported, the changes would allow HHS Secretary Robert F. Kennedy Jr. to rebuild the Advisory Committee on Immunization Practices with some or all of its previous members and resuscitate at least some of their decisions. One health expert told MedPage Today that it was "another alarming action by Secretary Kennedy."
By khnlaureno -
At GSK’s Request, FDA Rescinds Drug That Trump Touted To Treat Autism
The generic version of Wellcovorin is still available to cerebral folate deficiency patients. More administration news is about EPA rules on coal plant ash, the surgeon general nominee, potentially deeper health care cuts, and more.
By khnlaureno -
Eli Lilly Launches GLP-1 Pill Foundayo Via LillyDirect, Telehealth Across US
The once-daily oral obesity treatment could cost as little as $25 per month for those with a savings card. Medicare Part D users may also be able to get the drug for $50 beginning July 1. Meanwhile, Eli Lilly is seeing a dent in their sales due to generic GLP-1s flooding the market in India.
By khnlaureno